Santinelli’s unveils Xtrimer SE-1 industrial edging platform

Article

Santinelli International recently unveiled its Xtrimer SE-1 Industrial Edger featuring dry-cut lens edging technology.

Hauppauge, NY-Santinelli International recently unveiled its Xtrimer SE-1 Industrial Edger featuring dry-cut lens edging technology. The Xtrimer SE-1 has a “V” tool design, which introduces a new and efficient method of dry-cutting and milling, addressing the growing complexities of frame shapes and lens materials.

Incorporating 5 individual processing tools, the Xtrimer SE-1 expedites the roughing process on all organic lens materials, including Trivex and polycarbonate. The unit completes the 3-D cutting cycle and is capable of making tiltable bevel profiles (inclined bevels) and drilling a multitude of difficult shapes.

Job data and grinding condition settings are displayed in high-resolution graphics on the large, color LCD touch screen for easy job verification. Processing-command data can be entered using the iRx Editor tablet application. This application allows for real-time, interactive, remote support and combines useful functions such as sending/receiving of log files, software upgrades and more, for uninterrupted operation. Retouching after processing can be done automatically by entering the retouch information via the tablet.

The Xtrimer SE-1 is available as a stand-alone edger and is also engineered to operate in a small, medium or large volume capacity in conjunction with the company’s AES robotic units. 

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.